Stockscreener 앱 받기
72.48
4.18%
-3.16
시간 외 거래:
72.99
0.51
+0.70%
Ptc Therapeutics Inc 주식(PTCT)의 최신 뉴스
Momentum Shift: What is International Money Express Incs market positionTrade Exit Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn
First Week of September 18th Options Trading For PTC Therapeutics - Nasdaq
Does 2026 Revenue Guidance And Sephience Momentum Change The Bull Case For PTC Therapeutics (PTCT)? - Sahm
Discipline and Rules-Based Execution in PTCT Response - Stock Traders Daily
PTC Therapeutics projects FY26 product revenue between $700M to $800M - MSN
PTC Therapeutics reports $92.5M in Q4 Sephience revenue By Investing.com - Investing.com Nigeria
A Look At PTC Therapeutics (PTCT) Valuation As 2026 Revenue Guidance Reshapes Market Expectations - Sahm
Lobbying Update: $50,000 of PTC THERAPEUTICS INC. lobbying was just disclosed - Quiver Quantitative
Ptc Therapeutics CEO Klein sells $192k in shares By Investing.com - Investing.com Nigeria
Ptc Therapeutics CEO Klein sells $192k in shares - Investing.com
Utter, SVP at Ptc Therapeutics, sells $79k in shares By Investing.com - Investing.com Canada
Pauwels Eric, chief business officer of Ptc Therapeutics, sells $566k in shares - Investing.com Canada
PTC Therapeutics (NASDAQ:PTCT) VP Sells $180,330.02 in Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 4,602 Shares of Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 881 Shares of Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) EVP Lee Scott Golden Sells 866 Shares - MarketBeat
Eric Pauwels Sells 1,722 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) CAO Christine Marie Utter Sells 1,034 Shares of Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Shares Down 6.7%Here's Why - MarketBeat
PTC Therapeutics reports $92.5M in Q4 Sephience revenue - Investing.com
PTC Therapeutics, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
PTC Therapeutics Reports Preliminary 2025 Product Revenue, Sets 2026 Product Revenue Guidance - marketscreener.com
Ptc Therapeutics provides update at J.P. Morgan annual healthcare conference - marketscreener.com
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference - Yahoo Finance
PTC Therapeutics Inc (NASDAQ:PTCT) Emerges as a High-Growth Momentum Breakout Candidate - Chartmill
PTC Therapeutics, Inc. $PTCT Shares Purchased by SG Americas Securities LLC - MarketBeat
Market Outlook: Will PTC Therapeutics Inc stock sustain high P E ratios2025 EndofYear Setup & Expert Approved Trade Ideas - moha.gov.vn
PTC Therapeutics Inc (NASDAQ:PTCT) Combines Strong Growth with a Bullish Technical Setup - Chartmill
Is PTC Therapeutics Inc. stock a safe haven assetEarnings Risk Report & Growth Focused Stock Pick Reports - ulpravda.ru
PTC Therapeutics (NASDAQ:PTCT) EVP Sells $49,742.16 in Stock - MarketBeat
Neil Gregory Almstead Sells 1,026 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) CEO Matthew Klein Sells 3,016 Shares - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 1,279 Shares of Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) CAO Sells $95,650.75 in Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) CFO Sells 2,139 Shares of Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Insider Eric Pauwels Sells 1,789 Shares - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) CEO Matthew Klein Sells 5,149 Shares - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells 4,879 Shares of Stock - MarketBeat
Stop Loss: Is GDRX stock vulnerable to regulatory risksBuy Signal & Daily Momentum Trading Reports - moha.gov.vn
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GuruFocus
PTC Therapeutics Executives Engage in Stock Transactions - TradingView — Track All Markets
Is PTC Therapeutics Inc. stock a defensive play in 20252025 Price Targets & Smart Investment Allocation Tips - ulpravda.ru
What dividend safety score for PTC Therapeutics Inc. stockQuarterly Market Summary & High Yield Stock Recommendations - ulpravda.ru
RBC Lowers Price Target on PTC Therapeutics to $87 From $91, Keeps Sector Perform Rating - marketscreener.com
PTC THERAPEUTICS, INC. (PTCT) - MSN
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Rating of "Hold" from Analysts - MarketBeat
How Royalty Sale, Sephience Approval and CEO Share Sale At PTC Therapeutics (PTCT) Has Changed Its Investment Story - Sahm
PTC Therapeutics (NASDAQ:PTCT) VP Sells $171,196.30 in Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Director Emma Reeve Sells 734 Shares - MarketBeat
Glenn Md Phd Steele Jr Sells 12,000 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics Inc (PTCT) - MSN
PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating the Biotech Frontier with a 6.64% Potential Upside - DirectorsTalk Interviews
Is PTC Therapeutics Inc. stock supported by innovation pipeline2026 world cup usa national team round of 16 star players high defensive line odds analysis expert opinion - ulpravda.ru
A Look At PTC Therapeutics (PTCT) Valuation After Strong Recent Shareholder Returns - Sahm
PTC Therapeutics (NASDAQ:PTCT) Upgraded to Buy at Wall Street Zen - MarketBeat
Matthew Klein Sells 8,089 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics CEO Sells Shares to Cover Tax Obligations - TradingView — Track All Markets
Behavioral Patterns of PTCT and Institutional Flows - Stock Traders Daily
What's Going On With Royalty Pharma Stock Wednesday? - Benzinga
Duchenne Muscular Dystrophy (DMD) Therapeutics Market to Reach - openPR.com
Royalty Pharma Acquires Remaining Evrysdi Royalties From PTC Therapeutics - Nasdaq
Royalty Pharma Acquires Final Portion of Evrysdi Royalty from PTC Therapeutics for $240 Million - Quiver Quantitative
PTC Therapeutics Fully Monetizes Evrysdi Royalty Interest - TipRanks
PTC Therapeutics Signs Royalty Purchase Agreement Amendment With Royalty Pharma - TradingView — Track All Markets
4.73%
0.92%
자본화:
|
볼륨(24시간):